Back to KROS
Point72 Asset Management, L.P. → KROS
Point72 Asset Management, L.P. KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
15
Latest value
$760K
Q3 2026
Peak value
$64.3M
First seen
Q2 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2023 | $14M |
| Q3 2023 | $4.8M |
| Q4 2023 | $3.2M |
| Q1 2024 | $64.3M |
| Q2 2024 | $16.9M |
| Q2 2024 | $16.9M |
| Q2 2024 | $16.9M |
| Q3 2024 | $55M |
| Q4 2024 | $25K |
| Q1 2025 | $59 |
| Q1 2025 | $59 |
| Q4 2025 | $791K |
| Q1 2026 | $1.2M |
| Q2 2026 | $111K |
| Q3 2026 | $760K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $760K | 66.7K | — | — |
| Q2 2026 | $111K | 10.4K | — | — |
| Q1 2026 | $1.2M | 109.0K | — | — |
| Q4 2025 | $791K | 38.8K | — | — |
| Q1 2025 | $59 | 6 | — | — |
| Q1 2025 | $59 | 6 | — | — |
| Q4 2024 | $25K | 1.6K | — | — |
| Q3 2024 | $55M | 947.6K | — | — |
| Q2 2024 | $16.9M | 370.4K | — | — |
| Q2 2024 | $16.9M | 370.4K | — | — |
| Q2 2024 | $16.9M | 370.4K | — | — |
| Q1 2024 | $64.3M | 971.9K | — | — |
| Q4 2023 | $3.2M | 81.2K | — | — |
| Q3 2023 | $4.8M | 149.7K | — | — |
| Q2 2023 | $14M | 349.7K | — | — |